642 related articles for article (PubMed ID: 31075230)
1. Role of identified RNA N6-methyladenosine methylation in liver.
Xu K; Sun Y; Sheng B; Zheng Y; Wu X; Xu K
Anal Biochem; 2019 Aug; 578():45-50. PubMed ID: 31075230
[TBL] [Abstract][Full Text] [Related]
2. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA.
Liu N; Parisien M; Dai Q; Zheng G; He C; Pan T
RNA; 2013 Dec; 19(12):1848-56. PubMed ID: 24141618
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
Yue Y; Liu J; He C
Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
[TBL] [Abstract][Full Text] [Related]
4. N6-methyl-adenosine modification in messenger and long non-coding RNA.
Pan T
Trends Biochem Sci; 2013 Apr; 38(4):204-9. PubMed ID: 23337769
[TBL] [Abstract][Full Text] [Related]
5. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
6. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
Zhao Z; Meng J; Su R; Zhang J; Chen J; Ma X; Xia Q
J Hepatol; 2020 Sep; 73(3):664-679. PubMed ID: 32330603
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Maity A; Das B
FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
[TBL] [Abstract][Full Text] [Related]
8. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
9. Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
Sweaad WK; Stefanizzi FM; Chamorro-Jorganes A; Devaux Y; Emanueli C;
J Mol Cell Cardiol; 2021 Nov; 160():56-70. PubMed ID: 33991529
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of adipose tissue expansion and adipogenesis by N
Wu R; Wang X
Obes Rev; 2021 Feb; 22(2):e13124. PubMed ID: 32935469
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
12. m
He PC; He C
EMBO J; 2021 Feb; 40(3):e105977. PubMed ID: 33470439
[TBL] [Abstract][Full Text] [Related]
13. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
14. RNA
Li Y; Wang J; Huang C; Shen M; Zhan H; Xu K
Cell Biosci; 2020; 10():19. PubMed ID: 32110378
[No Abstract] [Full Text] [Related]
15. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
[TBL] [Abstract][Full Text] [Related]
17. Dynamic N6-methyladenosine RNA methylation in brain and diseases.
Shafik AM; Allen EG; Jin P
Epigenomics; 2020 Feb; 12(4):371-380. PubMed ID: 32081027
[TBL] [Abstract][Full Text] [Related]
18. RNA N6-methyladenosine in nonocular and ocular disease.
Wang N; Yao F; Liu D; Jiang H; Xia X; Xiong S
J Cell Physiol; 2022 Mar; 237(3):1686-1710. PubMed ID: 34913163
[TBL] [Abstract][Full Text] [Related]
19. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
20. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.
Luo Y; Zhang Z; Xiang L; Zhou B; Wang X; Lin Y; Ding X; Liu F; Lu Y; Peng Y
Front Endocrinol (Lausanne); 2021; 12():780617. PubMed ID: 34950107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
